IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $821,000 | -81.8% | 85,655 | -68.4% | 0.01% | -77.3% |
| Q1 2022 | $4,516,000 | +9.6% | 271,204 | +25.6% | 0.04% | +18.9% |
| Q4 2021 | $4,122,000 | -13.2% | 215,933 | +12.1% | 0.04% | -15.9% |
| Q3 2021 | $4,750,000 | +22.2% | 192,629 | +29.0% | 0.04% | +22.2% |
| Q2 2021 | $3,887,000 | -14.7% | 149,376 | +3.8% | 0.04% | -20.0% |
| Q1 2021 | $4,555,000 | -0.6% | 143,862 | +45.7% | 0.04% | -2.2% |
| Q4 2020 | $4,582,000 | +955.8% | 98,747 | +524.0% | 0.05% | +820.0% |
| Q2 2020 | $434,000 | -52.5% | 15,825 | -48.1% | 0.01% | -61.5% |
| Q1 2020 | $913,000 | -27.0% | 30,504 | -32.5% | 0.01% | -7.1% |
| Q4 2019 | $1,251,000 | +338.9% | 45,213 | +189.1% | 0.01% | +366.7% |
| Q3 2019 | $285,000 | +75.9% | 15,641 | +137.0% | 0.00% | +50.0% |
| Q2 2019 | $162,000 | – | 6,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |